Welcome to Market Catalyst. I'm Julie Heyman. 30 minutes into the US trading day. Let's take a look at the major averages. We are not seeing a heck of a lot of change here, but the NASDAQ and the S&P 500 did close on Friday at a record high. So, if either of them increases at all today, it will be another record close. But really, we see a lot of attention on later in the week. We've got President Trump and President Xi of China who are going to be meeting in China. So, some focus on that. We'll be getting ...

Novo agreed to hand over an experimental therapy for Parkinson’s disease to a Mark Zuckerberg-backed AI startup to potentially speed its development https://t.co/jpw19lhojW ...

Well, it's time for this weekend's Appointed News quiz. I'm excited, as always, to see how I fare. I know you're excited as well.Let's go. Lisa Mateo has the categories. I won the one yesterday.I feel like this one is going to go your way. That's the unofficial point of this quiz. The quasi quasi appointed.It's why I didn't invest so much into it. Huh. Yeah, that's. That's the reason.All right. Listen, listen. What charter do you have for us today.Okay, so for those of you playing at home, maybe you're not ...

Bloomberg News has been named a finalist for the 2026 Pulitzer Prize for Explanatory Reporting for Cancer Capitalism series, investigating drug companies and health providers’ profits. Read the stories https://t.co/J2TUrbX75G https://t.co/ByHUzYdEBo ...

Switzerland’s Sandoz sees Canada and Brazil markets as testing grounds before semaglutide goes off patent in Europe and the U.S. in the 2030s. https://t.co/9nEfnPUxlD ...

Novo Nordisk saw a 40% surge in sales of its diabetes and weight-loss drugs in India last month https://t.co/18aNVE0tWf ...

Gilead said it now expects to book a loss in 2026 on $11.5 billion in charges after deals to acquire a string of companies making experimental cancer and autoimmune disease drugs https://t.co/VqTjk0MPkh ...

Today in Bloomberg Deals: South Korea is drawing in beauty deals, plus Li Ka-shing eyes more telco sales and Italian drugmaker Angelini Pharma has agreed to buy Catalyst Pharmaceuticals for $4.1 billion. https://t.co/IfrokEf7vW ...

Eli Lilly’s blockbuster diabetes drug Mounjaro has surpassed Merck’s cancer therapy Keytruda as the world’s best-selling medication https://t.co/dYIeDbXsBz ...

Eli Lilly is spending another $4.5 billion on its manufacturing plants in Indiana as the pharmaceutical company shores up its domestic supply chain. https://t.co/0Kpx54TUjD ...